Abacavir
- Product NDC
- 70518-1274
- 11-digit product format
- 705181274
- Labeler code
- 70518
- Product ID
- 70518-1274_f05a16e4-0e69-224c-e053-2a95a90a90e6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abacavir
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA078119
- Marketing category
- ANDA
- Marketing start
- 2018-06-21
- Marketing end
- 0000-00-00
- Substance
- ABACAVIR SULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-1274-0 | 70518127400 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-1274-0) | 2018-06-21 | 0000-00-00 | No | No | Current |